Award

OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack

  • Belfast Health & Social Care Trust

UK6: Contract award notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2026/S 000-001042

Procurement identifier (OCID): ocds-h6vhtk-0600ec (view related notices)

Published 7 January 2026, 12:31pm



Scope

Reference

DACPM2025-51

Description

Procurement of OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack.


Contract 1. OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack

Supplier

Contract value

  • £4,000,000 excluding VAT
  • £4,000,000 including VAT

Above the relevant threshold

Award decision date

7 January 2026

Standstill period

  • End: 16 January 2026
  • 8 working days

Earliest date the contract will be signed

19 January 2026

Contract dates (estimated)

  • 19 January 2026 to 31 December 2027
  • 1 year, 11 months, 13 days

Main procurement category

Goods

CPV classifications

  • 33600000 - Pharmaceutical products

Contract locations

  • UKN - Northern Ireland

Procedure

Procedure type

Direct award


Supplier

LLOYDS CLINICAL LIMITED

  • Companies House: 02764914
  • Public Procurement Organisation Number: PDZG-6561-CPZD

Unit 4 Scimitar Park, Roydon Road

Harlow

CM19 5GU

United Kingdom

Region: UKH35 - West Essex

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Contract 1. OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack


Contracting authority

Belfast Health & Social Care Trust

  • Public Procurement Organisation Number: PLQJ-5727-JCLR

Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital

Belfast

BT12 6BA

United Kingdom

Region: UKN06 - Belfast

Organisation type: Public authority - central government

Devolved regulations that apply: Northern Ireland